Incyte officer Cagnoni proposes $320K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Incyte Corporation (INCY) officer Pablo Cagnoni reported a proposed sale of 2,642 common shares, with an approximate sale date of November 16, 2026, and an aggregate market value of $319,588.36. The notice lists the shares as acquired through a stock option exercise on November 16, 2026, with cash payment, and gives April 30, 2026 as the plan adoption or instruction date if relying on Rule 10b5-1. It also lists Cagnoni sales of 2,642 shares on October 15, 23,218 on September 15, and 10,801 on August 19, 2026.
Key Figures
Key Terms
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.